USPTO trademark

IZRIUS

Under examinationUSPTOWord markClass 5

"IZRIUS" is a word mark owned by Glaxo Group Limited, filed at the USPTO on October 6, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
IZRIUS trademark as filed
As filed with the USPTO
Status
Under examination
Since October 6, 2026
Filed
October 6, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50146286
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns IZRIUS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services IZRIUS is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About IZRIUS

Who owns the trademark "IZRIUS"?

The USPTO trademark "IZRIUS" (application 50146286) is owned by Glaxo Group Limited.

What is the status of "IZRIUS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IZRIUS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a11679-add4-72fa-a972-a74893b397cb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a11679-add4-72fa-a972-a74893b397cb",
  "object": "trademark",
  "mark_text": "IZRIUS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50146286",
  "filing_date": "2026-10-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}